ALX Oncology Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

NEXT STORY
Cellectis Appoints Biopharma Veteran Steve Doares, Ph.D., as Senior Vice President of US Manufacturing
PREV STORY
Aptose to Release Second Quarter Ended June 30, 2020 Financial Results and Hold Conference Call on August 4, 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Biocartis Group NV: Disclosure of a transparency notification

PRESS RELEASE: REGULATED INFORMATION28 January 2019, 07:00 CETDisclosure of a transparency notification Mechelen, Belgium, ...

author_avatar
NASDAQ Market News

Symphony Health Launches New Long Term Care Channel Offering

CONSHOHOCKEN, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Symphony Health, a PRA Health Sciences ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: RESOLUTIONS OF EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY SEPTEMBER 21, 2018

Company release September 21, 2018 at 1:15 PM EET RESOLUTIONS OF EXTRAORDINARY GENERAL MEETING OF ...

author_avatar
NASDAQ Market News